Nvidia Stock Rises As AI Chipmaker Plans Huge Share Buyback Nvidia signaled that it believes its stock is undervalued by announcing a huge increase to its share repurchase program.
Meta Stock Pulls Back After Muse-Fueled Rally. What Investors Are Watching Next. Meta stock is down for a second day after a sharp 30% rally that followed the launch of its Muse AI app.
Boeing Stock Skids On New 737 Issue, This One Affects Landings Boeing recently informed airlines of a new 737 Max software issue affecting navigation equipment during certain landings. BA stock slides.
Bitcoin Is Soaring Again. Will It Hit $100,000 by the End of 2026? Although Bitcoin is rallying, it's still nowhere near the highs it reached last year.
Fertilizer Prices Keep Climbing: 3 Stocks Still Trading at a Discount Wide U.S.-Europe natural gas spreads are boosting fertilizer margins. CF Industries, CVR Partners, and LSB Industries all trade below their spring highs despite strong spread economics.
The 10-Letter Word That Has the Market in a Panic Over Netflix Stock The once-hot streaming stock has been falling sharply this year due to concerns around engagement.
Should You Buy Tilray Brands Stock Before Oct. 8? The cannabis company is set to report its earnings early next month.
Snowflake Stock Falls Amid $3.5 billion Convertible Debt Offering Snowflake stock amid a $3.5 billion convertible debt offering amid investor concerns over potential equity dilution down the line.
Dell's AI Server Backlog Has Ballooned to $95 Billion. Here's What a $1,000 Investment Today Could Be Worth by 2030 Dell's potential AI server pipeline suggests the company is on track to deliver phenomenal growth over the next five years.
Lucid vs. Rivian Automotive: Which Electric Vehicle Stock Is a Better Buy in 2026? Lucid burns cash faster but trades cheaper. Rivian has deeper pockets and a VW partnership. But both face a brutal path to profitability.
Why 3 Struggling Stocks Are Suddenly Spending Big on Buybacks D.R. Horton, CAVA, and FTAI Aviation announced major buyback programs after share price declines, with D.R. Horton raising 2026 repurchase guidance 30% amid housing headwinds.
These AI Stocks Took Off Or Tumbled In Q3. Here's Why. AI stocks show diverging fortunes in Q3, with software plays and Nvidia rebounding while Ciena, CoreWeave, Broadcom and Google lagged.
Citi Sees $11 Billion Optical Networking Boom Driven By Google, Nvidia With investors anticipating the next-gen GPU platform for Nvidia stock, Citi forecasts an $11 billion optical switching market by 2030.
3 ETFs That Could Include Anthropic After Its IPO in October The new "fast track" inclusion rules mean that Anthropic could show up in ETFs just a few days after going public.
3 Niche Growth Stocks With an Edge Their Rivals Can’t Ignore Upstart, Sezzle, and Intuitive Machines show strong growth in niche markets, with rising revenue and demand, though each faces distinct risks like valuation, short interest, or cash burn.
3 Dividend Stocks With Higher Yields and Room for More Payout Growth JPMorgan, McDonald's, and VICI Properties raised dividends despite recent share-price weakness, with payout ratios suggesting each increase remains well supported by earnings and cash flow.
Interest Rates Are Climbing Again. Here's Where to Move Your Cash Now High-yield savings accounts are looking even better after the Fed's latest hike. See what counts as a good rate, plus what else to do with your cash today.
If a Bear Market Is Coming, Warren Buffett Says This is the Best Move Investors Can Make The stock market has been rallying for more than three years, but smart investors know the music won't go on forever.
Home Depot (HD) Is 32% Below Its All-Time High: Here's 1 Reason to Avoid the Stock Right Now Despite dominating the home improvement market, this company has been operating from a position of fundamental weakness.
Cullinan Therapeutics Eyes December Data Catalyst for CLN-978 and CLN-049 Cullinan Therapeutics (
NASDAQ:CGEM ) outlined upcoming clinical milestones across its immunology and oncology pipeline, including a planned December update for its CD19-directed T-cell engager CLN-978 and data presentations for other programs in November and the fourth quarter.
President and CEO Nad
Palantir's Stock Is Up Over 50% Since Reporting Earnings. Is It Heading for a New All-Time High? Investors are bullish on Palantir's stock due to not only the company's strong growth but also a convincing vision from CEO Alex Karp.
Inspirational Quotes: Melissa Butler, Bryan Cranston And Others Read inspirational quotes about finding your passion, building a powerful routine and conquering fear.
Here's Why You'll Probably Never Hit a 'Perfect' 850 Credit Score Reaching the very top of the credit scale takes decades of near-flawless habits, and most people get the same perks without ever getting there.
Is PayPal a Deep Value Play Right Now? PayPal's stock has cratered, but a new CEO, strong cash flow, and AI commerce bets could change the story. Here's what to watch.
In 5 Years, One of These Cryptocurrencies Could Be Worth More Than Bitcoin Although Bitcoin probably isn't going away, within five years it will be vulnerable to significant disruption.
The Unstoppable Monthly Dividend Stock to Buy and Hold Forever Realty Income offers a high yield, and it's been raising its payout for decades.
